Sanofi Navigates Patent Cliff, Expects Growth To Return In Second Half 2013
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi says the worst of its patent cliff is past, and with 15 new assets nearing the market in the next three years and an industry-leading business in emerging markets, the French group is well positioned for growth.